cutaneous malignancy

Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine
Eruptive squamous cell carcinoma JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …
Eruptive squamous cell carcinoma